Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Schoenenberger 2016 Cancer Res"

From Bioblast
 
(2 intermediate revisions by 2 users not shown)
Line 8: Line 8:


©2016 American Association for Cancer Research.
©2016 American Association for Cancer Research.
|mipnetlab=CH Zurich Gassmann M, CH Zurich Lundby C, US CO Colorado Springs Jacobs R
|mipnetlab=CH Zurich Gassmann M, CH Zurich Lundby C, US CO Colorado Springs Jacobs RA
}}
}}
{{Labeling
{{Labeling
|area=Respiration, nDNA;cell genetics
|area=Respiration, nDNA;cell genetics
|diseases=Cancer
|organism=Mouse
|organism=Mouse
|tissues=Nervous system
|tissues=Nervous system
|preparations=Permeabilized tissue
|preparations=Permeabilized tissue
|diseases=Cancer
|topics=ATP production
|topics=ATP production
|couplingstates=OXPHOS, ETS
|couplingstates=OXPHOS, ET
|pathways=F, N, S, CIV, NS, ROX
|pathways=F, N, S, CIV, NS, ROX
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=2016-09
|additional=2016-09
}}
}}

Latest revision as of 11:03, 28 March 2018

Publications in the MiPMap
Schönenberger D, Harlander S, Rajski M, Jacobs RA, Lundby AK, Adlesic M, Hejhal T, Wild PJ, Lundby C, Frew IJ (2016) Formation of renal cysts and tumors in Vhl/Trp53-deficient mice requires HIF1α and HIF2α. Cancer Res 76:2025-36.

» PMID: 26759234

Schoenenberger D, Harlander S, Rajski M, Jacobs RA, Lundby AK, Adlesic M, Hejhal T, Wild PJ, Lundby C, Frew IJ (2016) Cancer Res

Abstract: The von Hippel-Lindau (VHL) tumor suppressor gene is inactivated in the majority of clear cell renal cell carcinomas (ccRCC), but genetic ablation of Vhl alone in mouse models is insufficient to recapitulate human tumorigenesis. One function of pVHL is to regulate the stability of the hypoxia-inducible factors (HIF), which become constitutively activated in the absence of pVHL. In established ccRCC, HIF1α has been implicated as a renal tumor suppressor, whereas HIF2α is considered an oncoprotein. In this study, we investigated the contributions of HIF1α and HIF2α to ccRCC initiation in the context of Vhl deficiency. We found that deleting Vhl plus Hif1a or Hif2a specifically in the renal epithelium did not induce tumor formation. However, HIF1α and HIF2α differentially regulated cell proliferation, mitochondrial abundance and oxidative capacity, glycogen accumulation, and acquisition of a clear cell phenotype in Vhl-deficient renal epithelial cells. HIF1α, but not HIF2α, induced Warburg-like metabolism characterized by increased glycolysis, decreased oxygen consumption, and decreased ATP production in mouse embryonic fibroblasts, providing insights into the cellular changes potentially occurring in Vhl mutant renal cells before ccRCC formation. Importantly, deletion of either Hif1a or Hif2a completely prevented the formation of renal cysts and tumors in Vhl/Trp53 mutant mice. These findings argue that both HIF1α and HIF2α exert protumorigenic functions during the earliest stages of cyst and tumor formation in the kidney.

©2016 American Association for Cancer Research.


O2k-Network Lab: CH Zurich Gassmann M, CH Zurich Lundby C, US CO Colorado Springs Jacobs RA


Labels: MiParea: Respiration, nDNA;cell genetics  Pathology: Cancer 

Organism: Mouse  Tissue;cell: Nervous system  Preparation: Permeabilized tissue 

Regulation: ATP production  Coupling state: OXPHOS, ET  Pathway: F, N, S, CIV, NS, ROX  HRR: Oxygraph-2k 

2016-09